EUDA

+ Watchlist + Portfolio

Euda Health Holdings Limited

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $17.24
52-Week Range: $5.26 – $86.00
Market Cap: $51.80M
P/E (TTM): —
EPS (TTM): -1.16
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 8.67
PEG Ratio: —
Return on Equity: -211.36%
Return on Assets: -21.92%
Gross Margin: 47.57%
Operating Margin: -21.96%
Profit Margin: -32.69%
Current Ratio: 2.53
Debt/Equity: 0.06
Total Debt: $339.99K
Free Cash Flow: $-8.80M
Revenue Growth: 13.40%
Earnings Growth: —
Enterprise Value: $51.57M

EUDA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$3.76M	$3.71M	$4.01M	$6.82M
Cost of Revenue	$2.89M	$2.86M	$3.25M	$3.83M
Gross Profit	$870.00K	$842.08K	$762.15K	$2.99M
Research & Development	$17.21K	$0.00	$0.00	$249.00
Selling, General & Admin	$6.75M	$4.80M	$3.34M	$5.43M
Operating Expenses	$6.75M	$4.80M	$3.34M	$5.43M
Operating Income	-$5.88M	-$3.96M	-$2.58M	-$2.44M
EBITDA	-$24.76M	-$8.29M	-$17.42M	-$2.09M
Pretax Income	-$25.03M	-$8.43M	-$17.64M	-$2.73M
Income Tax	-$20.79K	$0.00	-$4.38K	$41.94K
Net Income	-$24.88M	-$10.04M	-$15.36M	-$2.77M
Diluted EPS	-41.40	-8.77	-9.46	—
Diluted Shares	601482	1.15M	1.62M	—

EUDA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$57.54K	$189.00K	$237.60K	$345.14K
Receivables	$22.09M	$239.19K	$170.27K	$334.20K
Inventory	—	$0.00	$128.98K	$2.84K
Current Assets	$25.03M	$723.44K	$762.88K	$1.04M
Total Assets	$25.63M	$1.31M	$1.70M	$1.72M
Current Liabilities	$29.12M	$8.72M	$4.14M	$5.84M
Total Debt	$3.63M	$3.37M	$1.27M	$2.40M
Total Liabilities	$29.14M	$8.79M	$4.27M	$5.98M
Retained Earnings	-$24.70M	-$34.74M	-$50.10M	-$52.87M
Shareholders' Equity	-$3.52M	-$7.50M	-$2.55M	-$4.25M
Working Capital	-$4.09M	-$7.99M	-$3.38M	-$4.80M
Net Debt	$3.51M	$2.98M	$804.02K	$1.86M

EUDA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$1.53M	-$2.92M	-$2.03M	-$2.43M
Capital Expenditure	-$18.14K	—	-$116.03K	-$104.45K
Free Cash Flow	-$1.53M	-$2.92M	-$2.15M	-$2.53M
Depreciation & Amortisation	$172.02K	$119.35K	$173.22K	$406.48K
Investing Cash Flow	-$268.21K	$0.00	-$147.77K	-$104.45K
Financing Cash Flow	$2.49M	$2.35M	$2.32M	$2.55M
Net Change in Cash	$693.91K	-$565.40K	$141.71K	$19.05K

EUDA Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q2 2025	Q4 2025
Cash & Equivalents	$237.60K	—	$345.14K
Receivables	$170.27K	—	$334.20K
Inventory	$128.98K	—	$2.84K
Current Assets	$762.88K	—	$1.04M
Total Assets	$1.70M	—	$1.72M
Current Liabilities	$4.14M	—	$5.84M
Total Debt	$1.27M	—	$2.40M
Total Liabilities	$4.27M	—	$5.98M
Retained Earnings	-$50.10M	—	-$52.87M
Shareholders' Equity	-$2.55M	—	-$4.25M
Working Capital	-$3.38M	—	-$4.80M
Net Debt	$804.02K	—	$1.86M

Market Snapshot

About

Euda Health Holdings Limited is a healthcare company focused on developing and commercializing medical devices and health-related products. The company operates in the medical technology sector, targeting specific therapeutic areas and patient populations with innovative solutions. Euda Health's business model includes product development, regulatory approval processes, and commercialization strategies for medical devices. The company seeks to address unmet needs in healthcare through its technology platforms and partnerships with healthcare providers and distributors.